127 related articles for article (PubMed ID: 20226889)
1. A comparative study of the serological response to Japanese encephalitis vaccine in HIV-infected and uninfected Thai children.
Chokephaibulkit K; Plipat N; Yoksan S; Phongsamart W; Lappra K; Chearskul P; Chearskul S; Wittawatmongkol O; Vanprapar N
Vaccine; 2010 Apr; 28(20):3563-6. PubMed ID: 20226889
[TBL] [Abstract][Full Text] [Related]
2. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
Vaccine; 2007 Nov; 25(49):8257-61. PubMed ID: 17964009
[TBL] [Abstract][Full Text] [Related]
3. A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine.
Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
Vaccine; 2010 Aug; 28(36):5900-2. PubMed ID: 20600498
[TBL] [Abstract][Full Text] [Related]
4. Response to JE vaccine among HIV-infected children, Bangkok, Thailand.
Rojanasuphot S; Shaffer N; Chotpitayasunondh T; Phumiamorn S; Mock P; Chearskul S; Waranawat N; Yuentrakul P; Mastro TD; Tsai TF
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):443-50. PubMed ID: 10437937
[TBL] [Abstract][Full Text] [Related]
5. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
Chotpitayasunondh T; Sohn YM; Yoksan S; Min J; Ohrr H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.
Muangchana C; Henprasertthae N; Nurach K; Theppang K; Yoocharoen P; Varinsathien P; Techathawat S; Sanohsieng S; Anantapreecha S
Vaccine; 2012 Jan; 30(2):361-7. PubMed ID: 22075090
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial.
Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Sabchareon A; Pancharoen C; Bouckenooghe A; Gailhardou S; Boaz M; Feroldi E
Pediatr Infect Dis J; 2010 Dec; 29(12):1111-7. PubMed ID: 20856164
[TBL] [Abstract][Full Text] [Related]
9. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK(®)V) in children.
Okada K; Iwasa T; Namazue J; Akechi M; Ueda S;
Vaccine; 2012 Sep; 30(41):5967-72. PubMed ID: 22841478
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.
Chanthavanich P; Limkittikul K; Sirivichayakul C; Chokejindachai W; Hattasingh W; Pengsaa K; Surangsrirat S; Srisuwannaporn T; Kaewma B; Yoksan S; Jun G; Zhumu B
Hum Vaccin Immunother; 2018 Apr; 14(4):900-905. PubMed ID: 29227177
[TBL] [Abstract][Full Text] [Related]
14. Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51.
Eder S; Dubischar-Kastner K; Firbas C; Jelinek T; Jilma B; Kaltenboeck A; Knappik M; Kollaritsch H; Kundi M; Paulke-Korinek M; Schuller E; Klade CS
Vaccine; 2011 Mar; 29(14):2607-12. PubMed ID: 21288804
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
16. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S
Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856
[TBL] [Abstract][Full Text] [Related]
17. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.
Feroldi E; Pancharoen C; Kosalaraksa P; Chokephaibulkit K; Boaz M; Meric C; Hutagalung Y; Bouckenooghe A
Pediatr Infect Dis J; 2014 Jun; 33(6):643-9. PubMed ID: 24717964
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Pancharoen C; Boaz M; Bouckenooghe A; Feroldi E
Vaccine; 2016 Nov; 34(46):5664-5669. PubMed ID: 27686833
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
Woolpert T; Staples JE; Faix DJ; Nett RJ; Kosoy OI; Biggerstaff BJ; Johnson BW; Sracic M; Fischer M
Vaccine; 2012 Apr; 30(20):3090-6. PubMed ID: 22406277
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.
Schuller E; Klade CS; Wölfl G; Kaltenböck A; Dewasthaly S; Tauber E
Vaccine; 2009 Mar; 27(15):2188-93. PubMed ID: 19200452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
